Long-term toxicity and health-related quality of life after adjuvant chemoradiation therapy or radiation therapy alone for high-risk endometrial cancer in the randomized PORTEC-3 trial

Author(s):
Post, C.C.B. (0000-0003-2534-6887); Boer, S.M. de; Powell, M.E.; Mileshkin, L.; Katsaros, D.; Bessette, P.; Haie-Meder, C.; Ottevanger, N.P.B.; Ledermann, J.A.; Khaw, P.; D'Amico, R.; Fyles, A.; Baron, M.H.; Kitchener, H.C.; Nijman, H.W.; Lutgens, L.C.H.W.; Brooks, S.; Jurgenliemk-Schulz, I.M.; Feeney, A.; Goss, G.; Fossati, R.; Ghatage, P.; Leary, A.; ; Lissoni, A.A.; McCormack, M.; Nout, R.A.; Verhoeven-Adema, K.W.; Smit, V.T.H.B.M.; Putter, H.; Creutzberg, C.L. (0000-0002-7008-4321)
Published
2021
Publication type
Article / Letter to editor
Date issued
2021-03-21
Language
English
Publisher
Elsevier
Is part of
International journal of radiation oncology, biology, physics (2021), Vol. 109, no. 4, p. 975-986
hdl
1887/3278805
doi
10.1016/j.ijrobp.2020.10.030
URL
https://www.sciencedirect.com/science/article/pii/S0360301620344473?via%3Dihub